Veeral Desai, Chief Strategy & Development Officer at agilon health, inc. (AGL), sold 425,428 shares at $22.74 ($9.6M) on 2022-04-19, disclosed to the SEC on 2022-04-21.
Open-market sale of $9.6M AGL by Chief Strategy & Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.74 | 106,357 | $2.4M | 25.2% |
| 2 | $22.74 | 106,357 | $2.4M | 25.2% |
| 3 | $22.34 | 106,357 | $2.4M | 24.8% |
| 4 | $22.34 | 106,357 | $2.4M | 24.8% |
| Total | $22.54 avg | 425,428 | $9.6M | 100% |
| Filing → |
| AGL | SELL | 2023-03-27 | $4.1M | — | Filing → |
| AGL | SELL | 2023-03-17 | $1.6M | — | Filing → |
| AGL | SELL | 2022-07-25 | $2.2M | — | Filing → |